AVAH:NSD-Aveanna Healthcare Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 4.91

Change

+0.01 (+0.20)%

Market Cap

USD 0.96B

Volume

0.12M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia. Address: 400 Interstate North Parkway SE, Atlanta, GA, United States, 30339

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.90 (-0.57%)

USD 8.50B
OPCH Option Care Health Inc

-6.95 (-22.79%)

USD 5.14B
ACHC Acadia Healthcare Company Inc

+0.48 (+0.93%)

USD 4.84B
SGRY Surgery Partners Inc

-0.65 (-2.16%)

USD 4.02B
AMED Amedisys Inc

-0.08 (-0.08%)

USD 3.12B
LFST Lifestance Health Group Inc

-0.01 (-0.15%)

USD 2.67B
ASTH Astrana Health Inc

-0.23 (-0.41%)

USD 2.55B
ADUS Addus HomeCare Corporation

-4.09 (-3.15%)

USD 2.35B
HCSG Healthcare Services Group Inc

+0.03 (+0.27%)

USD 0.76B
CMPS Compass Pathways Plc

-0.03 (-0.48%)

USD 0.44B

ETFs Containing AVAH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 83.21% 85% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.21% 85% B 79% B-
Trailing 12 Months  
Capital Gain 243.36% 89% A- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 243.36% 89% A- 84% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 17.07% 63% D 72% C
Dividend Return 17.07% 63% D 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 104.65% 26% F 20% F
Risk Adjusted Return 16.31% 63% D 51% F
Market Capitalization 0.96B 68% D+ 71% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector